Is Ibogaine Legal in U.S.? Medical and Legal Risks Explained

Is ibogaine legal in the U.S.? No. Ibogaine is illegal federally in the United States. It is classified as a Schedule I controlled substance. Ibogaine is not FDA-approved for addiction treatment, opioid withdrawal symptoms, trauma, depression, psychedelic therapy, or any other medical use.

However, psychedelics are gaining steam therapeutically. U.S. digital news outlet Axios has reported that there are more than 200 psilocybin clinical trials underway worldwide. Ibogaine is quite different, with far fewer clinical trials. But it has made recent headlines and may hold therapeutic promise for the future.

For now, ibogaine remains controversial even beyond its legality. It also also carries serious medical risks, including heart rhythm problems and deaths reported in some literature.

In this guide, we're getting real on ibogaine's legal status and sharing information that anyone considering this powerful psychedelic should know: why U.S. clinics generally cannot offer it, what research says so far, and why medical supervision and safety protocols are key to any serious ibogaine discussion. Let's get to it!

What Is Ibogaine?

Ibogaine is a psychoactive compound found in the Tabernanthe iboga plant, a shrub native to Central Africa. The iboga root has traditional uses in parts of Central Africa, including spiritual practices. Modern interest in ibogaine was sparked by reports that it appeared to reduce withdrawal symptoms and opioid cravings in some people with substance use issues.

Ibogaine is complex. It is not a stimulant, sedative, classic psychedelic, or prescription drug. It interacts with multiple systems that may be relevant to addiction recovery, including serotonin transport, opioid receptors, and neurotransmitter systems. That complexity is one reason ibogaine research continues, but it is also one reason safety is difficult to manage.(1)

Ibogaine is sometimes described as an “anti-addiction drug ibogaine." That phrase is too strong for current U.S. medical use. Early research and observations suggest possible effects on withdrawal symptoms, opioid cravings and substance use. But ibogaine is not an accepted medical treatment in the United States.

For more background on psychoactive compounds, check out our educational guide on potential psychedelic mushroom benefits.

A word on Psilocybin Mushrooms

For context, let's quickly pivot from ibogaine to its more well-established psychedelic counterpart: magic mushrooms (psilocybin).

• Psilocybin use is now measurable nationally: A 2024 RAND national survey found that 3.1% of U.S. adults reported using psilocybin mushrooms in the past year, making psilocybin the most commonly used psychedelic in the U.S. Read about microdosing psilocybin mushrooms.
• MDMA therapy reached late-stage FDA review: MDMA-assisted therapy for PTSD advanced through two late-stage trials involving more than 190 patients before the FDA declined approval in 2024 and requested more data.
• Ibogaine is also attracting attention: Texas has considered investing up to $50 million in clinical trials for ibogaine, especially in the context of helping veterans.

Together, these developments show why ibogaine is part of a much larger psychedelic therapy conversation. Psilocybin, MDMA, ketamine-related models, and ibogaine are all being discussed more seriously than they were a decade ago.

Why People Seek Ibogaine

People usually do not search for ibogaine casually. Many are trying to figure out if it is legal because they or someone they love is struggling with substance use issues, alcohol abuse, traumatic brain injuries, depression, trauma, or other mental health conditions.

The most common reasons people seek ibogaine include:

• Opioid withdrawal symptoms: Some reports suggest ibogaine may reduce withdrawal symptoms after opioid use.
• Opioid cravings: Observational studies have reported reductions in opioid cravings after ibogaine treatment, though evidence is early.
• Substance use disorders: Ibogaine has been discussed in relation to opioids, cocaine, alcohol and other substances, but it is not an FDA-approved treatment.
• Trauma and mental health: Some people seek ibogaine therapy or psychedelic therapy for trauma, depression, PTSD-like symptoms, or spiritual goals.

If you are asking “is ibogaine legal in the US,” you may be looking for legal treatment options, considering travel, looking at credible clinics abroad, or looking for clinical trials.

Is Ibogaine Legal in the US?

No. Ibogaine is illegal federally in the United States. The Drug Enforcement Administration lists ibogaine as a Schedule I controlled substance, code number 7260, and identifies it as a constituent of the Tabernanthe iboga plant.(3)

Under the Controlled Substances Act, Schedule I is the most restrictive category. Schedule I substances are drugs or other substances with high potential for abuse, no currently accepted medical use in the United States, and a lack of safety data under medical supervision.(2)

Some people assume psychedelic drugs become legal when cities or states decriminalize certain plants or due to positive shifts on how researchers regard psychedelic medicine. That is not a safe assumption. Federal Schedule I status still controls ibogaine at the national level.

The current legal status is straightforward: ibogaine is illegal federally, not medically accepted under U.S. federal scheduling, and not available as legal ibogaine treatment through ordinary U.S. medical care. It is not FDA-approved for any medical use.

Read about the legality of nootropic supplements.

Did you know? FDA-approved medications for opioid use disorder include buprenorphine, methadone and naltrexone. These are all are used within clinical guidelines rather than underground psychedelic treatment settings.(4)

Can U.S. Clinics Offer Ibogaine?

Generally, no. U.S. clinics cannot legally offer ibogaine treatment as a routine service because ibogaine is a Schedule I controlled substance and is not FDA-approved. A clinic advertising ibogaine therapy, ibogaine detox, or ibogaine treatment centers inside the United States should be treated with extreme caution.

If a U.S. business claims ibogaine treatment is legal because it is “natural,” “spiritual,” “not a drug,” “for research,” or “not FDA-regulated,” that is not a reliable legal argument. The use of ibogaine is controlled by federal law, and the fact that it comes from a plant does not make possession, importation, administration or treatment legal.

Ibogaine Research in the US

Ibogaine research exists, but the clinical evidence is still early and complicated by safety concerns. Much of the human evidence comes from weaker studies rather than large, blinded, randomized controlled trials. Let's take a look at some of the research.

• In a 2018 observational study of ibogaine for opioid use disorder in Mexico, researchers reported reductions in opioid withdrawal symptoms and drug use outcomes. The study was not a randomized controlled trial, and follow-up was difficult, but it helped document why ibogaine is researched for addiction.(5)
• Another 2018 observational study followed people receiving ibogaine treatment for opioid dependence in New Zealand over 12 months. Researchers reported that some participants reduced or stopped opioid use, but the study also included serious safety concerns, including one death during treatment.(6)
• A clinical observations study published in Frontiers in Pharmacology described ibogaine-assisted detoxification in opioid and cocaine users and reported improvements in withdrawal and craving measures. However, the authors framed the findings as clinical observations, not definitive proof.(7)
• A 2022 systematic review of clinical trials and therapeutic applications concluded that ibogaine and noribogaine show therapeutic potential for substance abuse and related psychological symptoms, but the authors also emphasized limited evidence quality and the need for definitive safety data.(8)

For U.S. readers, the takeaway is cautious: ibogaine research is real, but it is early.

Safety Risks

Safety is the biggest reason ibogaine should not be discussed like ordinary psychedelic therapy or a simple detox aid. Ibogaine is medically risky:

Heart Rhythm Risk

Ibogaine has been associated with QT prolongation and arrhythmia risk. A review focused on ibogaine and the heart described a “delicate relation” between ibogaine’s anti-addiction interest and its cardiac risks, including effects that may contribute to potentially dangerous rhythm disturbances.(9) Another pharmacology study reported that ibogaine may be linked to cardiac arrhythmia risk. This is one reason medical screening and continuous cardiac monitoring are crucial to ibogaine safety discussions.(10)

Deaths and Severe Adverse Events

Deaths have been linked to ibogaine ingestion. However, one review emphasized the difficulty of separating ibogaine’s direct effects from other risk factors.(11) A more recent systematic review of reported serious ibogaine-associated emergencies, including deaths, and emphasized that ibogaine safety cannot be assumed.(12)

Drug Interactions and Opioid Risk

Ibogaine use can be especially dangerous in the context of opioid use, benzodiazepines, stimulants, alcohol, psychiatric medications, certain prescription drugs and other psychoactive substances. This is why “detox” is not the same as addiction recovery. Evidence-based addiction treatment typically includes ongoing care, relapse prevention, behavioral support, medication (sometimes), and mental health care.

Psychiatric and Neurological Risks

Because ibogaine is a powerful psychoactive substance, it may have additional risks for people with serious mental illness, mania risk, psychosis risk, suicidality, panic, severe anxiety, unstable mood, or trauma-related symptoms.

Medical Supervision Is Not Optional

Even in countries where ibogaine treatment centers operate, safety depends heavily on screening, ECG monitoring, electrolyte management, emergency readiness, medication review, substance-use assessment and qualified clinical supervision. Without all of these elements, ibogaine use may be especially dangerous.

International Ibogaine Treatment Context

Because ibogaine is illegal in the United States, some people consider international ibogaine treatment centers. Various ibogaine treatment centers have operated in countries such as Mexico, Canada, South Africa, New Zealand and others, but legality and regulation vary by country and may change over time.

Traveling abroad does not remove medical risk. International clinics may differ dramatically in safety protocols and physician involvement. Some may be medically credible; others may be poorly regulated or unsafe.

FAQ

Is ibogaine legal in the U.S.?

No. Ibogaine is illegal federally in the U.S. It is classified as a Schedule I controlled substance under federal law.

Is ibogaine a Schedule I drug?

Yes. The DEA lists ibogaine as a Schedule I controlled substance. Schedule I status means federal law does not recognize currently accepted medical use in treatment in the United States and treats the substance as having high abuse potential and lack of accepted safety under medical supervision.

Is ibogaine FDA-approved?

No. Ibogaine is not FDA-approved for opioid use disorder, addiction recovery, depression, trauma, traumatic brain injuries, alcohol abuse, psychedelic therapy, or any other medical use.

Can U.S. clinics legally offer ibogaine treatment?

Generally no. U.S. clinics cannot legally offer routine ibogaine treatment because ibogaine is a Schedule I controlled substance and not an FDA-approved medical treatment. Legal access would generally require authorized research or clinical trial pathways.

Can I import ibogaine for personal use?

No. Because ibogaine is federally controlled, importing ibogaine into the United States can create serious legal risk. Do not attempt to import ibogaine without qualified legal guidance and appropriate federal authorization.

Can I travel outside the U.S. for ibogaine treatment?

Some people travel internationally to seek ibogaine treatment, but legality and safety standards vary by country and clinic. Travel does not make ibogaine safe, and it does not change U.S. federal law regarding possession, importation or administration inside the United States.

Is ibogaine safe?

Ibogaine is medically risky. It has been associated with QT prolongation, arrhythmias, severe adverse events, drug interactions and deaths. Anyone with substance use disorders, opioid use, heart risk, psychiatric instability or medication use should seek evidence-based medical care rather than self-administering ibogaine.

Summary

Is ibogaine legal in the U.S.? No. Ibogaine is illegal federally, classified as a Schedule I controlled substance, and not FDA-approved for any medical use. That means ibogaine treatment is not legally available through ordinary U.S. clinics, prescriptions or addiction treatment centers.

Ibogaine research continues because early studies and observational reports suggest possible effects on withdrawal symptoms, opioid cravings and substance use disorders. But the evidence is not strong enough to establish accepted medical use, and the safety concerns are significant.

The bottom line is clear: ibogaine is legally restricted, medically risky, and not an approved treatment drug in the United States. People seeking help for opioid use disorder, drug and alcohol abuse, mental health conditions, trauma, or addiction recovery should prioritize licensed medical professionals, evidence-based treatment, approved medications, clinical supervision and legitimate clinical trials when available.